| 摘要 |
The inventive method consists in correcting pathological immune responses by using an activated form of ultra-small doses of monoclonal, polyclonal and natural anti-cytokine antibodies which determine an inflammation course, including autoimmune inflammation. Said form is produced by repetitive successive dilution and an external action being used mainly by means of homeopathic technology. The mixture of the activated forms of antibodies to different cytokines, which determine the inflammation course, can be used. An activated form of antibodies to a tumour necrosis factor alpha which is based on antibodies to a tumour necrosis factor alpha (TNF- ?) is used as a medicinal agent for correcting pathological immune responses. Said activated form of antibodies to TNF-? is produced by a repetitive successive dilution and an external action, mainly using a homeopathic technology, preferably in the form of a mixture of different, mainly centesimal, homeopathic dilutions. |
